Sector ratings Bio-Techne Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-15 pm EST			5-day change	1st Jan Change
75.13 ^USD	+0.54%		-0.08%	+4.30%

Jan. 14	Bio-Techne Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 10:30 AM
Jan. 10	Bio-Techne Expands R&D Systems Ai-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine	CI

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	ESG MSCI	Capi. ($)
BIO-TECHNE CORPORATION		A	11.94B
LONZA GROUP AG		AAA	43.05B
IQVIA HOLDINGS INC.		AA	35.59B
CELLTRION, INC.		B	26.74B
ICON PUBLIC LIMITED COMPANY		AA	16.47B
UNITED THERAPEUTICS CORPORATION		BBB	16.15B
MODERNA, INC.	-	AA	13.38B
MEDPACE HOLDINGS, INC.		BBB	10.4B
QIAGEN N.V.		AAA	10.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		A	8.89B
REVOLUTION MEDICINES, INC.	-	BB	7.38B
BLUEPRINT MEDICINES CORPORATION		B	6.66B
PHARMARON BEIJING CO., LTD.		AA	5.53B
HANGZHOU TIGERMED CONSULTING CO., LTD		AA	5.51B
TELIX PHARMACEUTICALS LIMITED		A	5.23B
IONIS PHARMACEUTICALS, INC.	-	BB	5.24B
ALKERMES PLC		A	4.7B
BACHEM HOLDING AG		BBB	4.67B
Average		A	13.2B
Weighted average by Cap.		A